The effects of corticosteroids on the trafficking, number and function of the lymphocytes and monocytes have been assumed to be the mechanism of therapeutic efficacy of ACTH in MS and other immune/inflammatory mediated diseases. This evidence concerns the gene POMC and myeloid sarcoma.